One in Six Billion podcast

A podcast about diabetes and genes

With Andrew Hattersley
and Maggie Shepherd

Series 2 Episode 2. Moira Murphy and Mark McCarthy. Defining the genetic susceptibility to Type 2 diabetes

Posted by Design Studio

Released 11 June 2024
Moira Murphy and Mark McCarthy talk about how a unified UK team of scientists came to be world leaders in decoding the genetic susceptibility to Type 2 diabetes.

In this episode Dr Moira Murphy the Research Director for the charity Diabetes UK and Professor Mark McCarthy a world leading Type 2 geneticist who worked in London and Oxford talk to Andrew and Maggie. They describe how, under Moira’s leadership, 6 centres in the UK (Exeter, Oxford, Imperial, Royal London, Newcastle and Norwich/Cambridge) worked together and become world leading in describing the genetic changes that make you more likely to develop Type 2 diabetes.  The first major breakthrough was in 2007 when they published one of the very first genomewide association scans for Type 2 diabetes

This is the paper that was published in Science in April 2007.

https://pubmed.ncbi.nlm.nih.gov/17463249/

 

Two sisters who were both living with Type 2 diabetes that volunteered to support the Diabetes UK funded Warren 2 project to help find the genetic susceptibility to Type 2 diabetes.
The 6 collecting centres were distributed in Exeter, London (x2), Newcastle, Norwich and Oxford.
Part of the Warren 2 collection team stand outside the old British Diabetic Association London headquarters in 1995 including a very young Andrew Hattersley and Mark McCarthy.

More about today’s guests

Dr Moira Murphy

Dr Moira Murphy was the research director of Diabetes UK between 1989 and 2003  although before 2000 this charity was called the British Diabetic Association (BDA).  Moira was a scientist, who did a PhD after her degree.  After initially working in the pharmaceutical industry she decided to take the post as the scientific director for the UK’s leading diabetes charity.  In this post she led the research spending of the charity. She was fundamental in the decision to support the early work in the genetics of diabetes by funding, using the Warren bequest, the collection of  blood to make DNA samples from people living with diabetes including Type 1 diabetes , Type 2 diabetes and monogenic diabetes.  Her decision that all the UK groups working in Type 2 diabetes must work together if they were to receive funding was critical for the success of the UK research teams in genetics of Type 2 diabetes on the world stage

Professor Mark McCarthy

Professor Mark McCarthy trained as a doctor working in diabetes and endocrinology in Cambridge and London. In his final years of his medical training he went into research into the genetics of Type 2 diabetes, working with Prof. Graham Hitman (Royal London). A year spent in Boston USA with Eric Lander in the mid 90s was transformative to his approach to the genetics of complex disease like Type 2 diabetes. On his return to the UK, he took up a joint clinical and research post at Imperial College, London, and built a team working on the genetics of type 2 diabetes. In 2002 he moved to Oxford as Robert Turner Professor of Diabetic Medicine and stayed there till his move to take up the position of Senior Director in Human Genetics at Genentech in June 2019.  Mark was an early pioneer in the genetics of Type 2 diabetes co-leading the collection of DNA from patients throughout the UK and leading the Type 2 diabetes component of the Wellcome Trust Case Consortium that published in 2007.  He is a world leader in the genetics of complex disease and is one of the most cited scientists in diabetes.